By Padmanabhan Ananthan Aug 26 (Reuters) – The U.S. FDA has approved Revolution Medicines' groundbreaking pancreatic cancer drug after it was shown to double the survival rate of patients with
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Morning Bid: Let the doves sing
A look at the day ahead in European and global markets from Rocky Swift With…
Footage of proposed Rwanda F1 site
VIDEO SHOWS: GVS OF PROPOSED RWANDA F1 CIRCUIT SITE PLEASE SEE EDITS: 9715-MOTOR-F1-RWANDA ; 9717-MOTOR-F1-RWANDA/ …
Pius Suter, Mason McTavish help Blues wallop Senators 7-2
Pius Suter and Mason McTavish each had two goals and an assist in the St.…
